GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Adastra Holdings Ltd (XCNQ:XTRX) » Definitions » EBITDA Margin %

Adastra Holdings (XCNQ:XTRX) EBITDA Margin % : 6.73% (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Adastra Holdings EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Adastra Holdings's EBITDA for the three months ended in Sep. 2024 was C$0.48 Mil. Adastra Holdings's Revenue for the three months ended in Sep. 2024 was C$7.10 Mil. Therefore, Adastra Holdings's EBITDA margin for the quarter that ended in Sep. 2024 was 6.73%.


Adastra Holdings EBITDA Margin % Historical Data

The historical data trend for Adastra Holdings's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adastra Holdings EBITDA Margin % Chart

Adastra Holdings Annual Data
Trend Apr19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
- -263.55 -24.69 -19.69 -6.35

Adastra Holdings Quarterly Data
Oct18 Oct19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.28 -0.76 -21.98 -10.20 6.73

Competitive Comparison of Adastra Holdings's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Adastra Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adastra Holdings's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Adastra Holdings's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Adastra Holdings's EBITDA Margin % falls into.



Adastra Holdings EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Adastra Holdings's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-1.411/22.223
=-6.35 %

Adastra Holdings's EBITDA Margin % for the quarter that ended in Sep. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=0.478/7.104
=6.73 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Adastra Holdings  (XCNQ:XTRX) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Adastra Holdings EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Adastra Holdings's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Adastra Holdings Business Description

Traded in Other Exchanges
Address
275th Street, Suite 5451, Langley, BC, CAN, V4W 3X8
Adastra Holdings Ltd is an extraction and processing solutions company. It aims to develop and deploy large-scale cannabis and hemp extraction technologies and provide turnkey processing solutions to help licensed standard and micro-cultivators maximize the value of every harvest. The company has two operating segments comprised of manufacturing and non-manufacturing operations. The manufacturing operations include the manufacturing, sale, and distribution of cannabis-related products, and the non-manufacturing operations include PerceiveMD.
Executives
Lachlan Clyde Mcleod Senior Officer
Michael Forbes Director, Senior Officer
Donald Dinsmore Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)

Adastra Holdings Headlines

No Headlines